Company / R&D per Share
Zoetis R&D per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$1.56
FY2025
5-year range
$0.96 / $1.56
FY2021-FY2025
Trend
+4.0%
vs FY2024
Sector context
#122 of 208
Health Care
What the data says
At $1.56, Zoetis's r&d per share ranks #122 of 208 in the Health Care sector. R&D per Share has increased for 5 consecutive years, from $0.91 in FY2020 to $1.56 in FY2025.
Based on SEC 10-K filings.
1.56 in FY2025 with a 5-year CAGR of +11.4%.
Improved from $1.10 to $1.56 over the past 2 years.
Health Care sector context is included.
R&D per Share over time
Growth rates
- 3-Year CAGR
- +16.7%
- 5-Year CAGR
- +11.4%
- 10-Year CAGR
- -
Sector benchmark
#122 of 208 in Health CareTop 59% of 208This company $1.56 Sector average $28.82
▼
-94.6% below sector average
Key checks
Key Insights
- Zoetis's r&d per share has grown for 5 consecutive years.
- In FY2025, r&d per share increased 4.0% year-over-year.
- Ranks #122 out of 208 companies in the Health Care sector.
- Lowest r&d per share in the period was in FY2017.
Company context
Key Data Points
- Strong profit margin: 28.2%
- Strong return on equity: 49.1%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.56 | +4.0% |
| FY2024 | $1.50 | +36.6% |
| FY2023 | $1.10 | +11.8% |
| FY2022 | $0.98 | +1.9% |
| FY2021 | $0.96 | +5.8% |
| FY2020 | $0.91 | -4.7% |
| FY2019 | $0.95 | +7.2% |
| FY2018 | $0.89 | +20.3% |
| FY2017 | $0.74 | -7.2% |
| FY2016 | $0.80 | +0.0% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026